Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Drugs Made In America Acq...

    NASDAQ: DMAA · Real-Time Price · USD
    10.27
    0.00 (0.00%)
    At close: Oct 03, 2025, 3:39 PM
    10.49
    2.14%
    Pre-market: Oct 06, 2025, 07:25 AM EDT

    Drugs Made In America Acquisition Ordinary Shares Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024
    PE Ratio
    		 37.35 0.02 -76.49 -0.15 -388.57
    PEG Ratio
    		 -0.37 -0.00 -0.14 0.01 n/a
    PS Ratio
    		 n/a n/a n/a n/a n/a
    PB Ratio
    		 1.50 0.00 -349.87 -0.52 -4.28K
    P/FCF Ratio
    		 -1.14K -0.38 -694.04 -1.49 -742.86
    P/OCF Ratio
    		 -1.14K -0.38 -694.04 -1.49 -742.86
    OCF/S Ratio
    		 n/a n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a 0.00 -2.71 -3.35 -10.54
    Quick Ratio
    		 0.16 0.20 0.01 0.00 0.37
    Current Ratio
    		 0.16 0.20 0.01 0.00 0.37
    Asset Turnover
    		 n/a n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a n/a
    Return on Equity
    		 0.01 0.01 1.14 0.88 2.76
    Return on Assets
    		 0.01 0.01 -0.51 -0.34 -0.29
    Return on Invested Capital
    		 n/a n/a -0.67 -0.37 -0.29
    Dividend Yield
    		 n/a n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a n/a

    Add to Watchlist